carrier screening
Sema4 Q3 Revenues Rise 12 Percent
For the quarter ended Sept. 30, the firm reported $43.2 million in revenues, up from $38.6 million in Q3 of 2020 and beating the average Wall Street estimate.
UK Biobank Study Investigates Incomplete Penetrance of Mendelian Disease Variants
The study, presented at the virtual ASHG annual meeting this week, analyzed phenotypes in carriers of different recessive Mendelian diseases.
The genetic testing and health intelligence firm will start trading on the Nasdaq Global Select Market on Friday under the ticker symbols SMFR and SMFRW.
ACMG Updates Carrier Screening Recommendations for Autosomal Recessive, X-Linked Conditions
The updated ACMG guidelines on carrier screening recommended a consistent and more equitable approach to testing.
The company believes its molecular counting technology can offer improved sensitivity for advanced cancer genotyping and longitudinal monitoring of response to therapy.
Nov 9, 2020
Progenity Q3 Revenues Increase 38 Percent
Oct 23, 2020
BTIG Initiates Coverage of Progenity With Buy Rating
Mar 10, 2020
BillionToOne Closes $15M Series A Follow-on Round
Nov 12, 2019
Aug 7, 2019
Natera Q2 Revenues Rise 18 Percent
Jan 30, 2019
ArcherDx Acquires Baby Genes
Dec 20, 2018
May 30, 2018